Afuco™ Anti-SLAMF7 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-743)

CAT#: AFC-TAB-743

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. It is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.

Gene Expression
Figure 1 IF staining of human cell line SK-MEL-30 Figure 2 Testis Figure 3 Colon Figure 4 Liver Figure 5 Kidney Figure 6 RNA cell line category: Cell line enriched (U-266/70)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Elotuzumab
  • Related Disease
  • Multiple myeloma (MM)

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • SLAMF7; SLAM family member 7; 19A; CD319; CRACC; CS1; protein 19A; CD2 subset 1; 19A24 protein; membrane protein FOAP-12; CD2-like receptor activating cytotoxic cells
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-743. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Elotuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Elotuzumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "elotuzumab"

Anti-SLAMF7 Recombinant Antibody (Elotuzumab)
Recombinant humanized antibody expressed in CHO binding to human SLAMF7/CD319. Elotuzumab is a humanized monoclonal antibody which is under phase III clinical investigation in relapsed multiple myeloma.
DrugMonitor™ Anti-Elotuzumab Antibody (VS-1224-YC413)
Elotuzumab is a humanized IgG1 monoclonal antibody indicated for use with lenalidomide and dexamethasone in multiple myeloma treatment. The DrugMonitor™ Anti-Elotuzumab Antibody (VS-1224-YC413) is an anti-drug antibody (ADA) against Elotuzumab. This drug-based antibody is raised in mice immunized with the Elotuzumab. The anti-Elotuzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Elotuzumab in samples.

See other products for "SLAMF7"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-743 Anti-SLAMF7 Recombinant Antibody (Elotuzumab) FuncS, IF, Neut, ELISA, FC, IP, IHC IgG1 - kappa
TAB-570CL Human Anti-SLAMF7 Recombinant Antibody (TAB-570CL) IF, IHC, Inhib Human IgG
CAT Product Name Application Type
HPAB-AP796-YC Mouse Anti-SLAMF7 Recombinant Antibody (HPAB-AP796-YC) ELISA, FC, IHC, Inhib Mouse IgG1
HPAB-AP797-YC Mouse Anti-SLAMF7 Recombinant Antibody (HPAB-AP797-YC) ELISA, FC, IHC, Inhib Mouse IgG2a
HPAB-AP798-YC Mouse Anti-SLAMF7 Recombinant Antibody (HPAB-AP798-YC) ELISA, FC, IHC, Inhib Mouse IgG2b
HPAB-AP799-YC Human Anti-SLAMF7 Recombinant Antibody (HPAB-AP799-YC) ELISA, FC, IHC, Inhib, ADCC, FuncS Humanized IgG1
HPAB-AP800-YC Human Anti-SLAMF7 Recombinant Antibody (HPAB-AP800-YC) ELISA, FC, IHC, Inhib, ADCC, FuncS Chimeric (Mouse/Human) IgG1, κ
CAT Product Name Application Type
VS-0424-XY237 AbPlus™ Anti-SLAMF7 Magnetic Beads (DM10) IP, Protein Purification
CAT Product Name Application Type
VS-0225-XY199 CytoStream™ Mouse Anti-SLAMF7 Recombinant Antibody (VS-0225-XY199) FC Mouse IgG2a, kappa
CAT Product Name Application Type
VS-0425-FY183 Human Anti-SLAMF7 (clone Elotuzumab) scFv-Fc Chimera ELISA, FC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC83 Recombinant Anti-SLAMF7 Vesicular Antibody, EV Displayed (VS-0425-YC83) ELISA, FC, Neut, Cell-uptake
CAT Product Name Application Type
VS-0525-XY6620 Anti-SLAMF7 Immunohistochemistry Kit IHC
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare